The Timolol Market is a vital segment within the pharmaceutical industry, primarily driven by the increasing prevalence of glaucoma and other cardiovascular diseases. Timolol, a non-selective beta-adrenergic antagonist, is widely used in ophthalmology to reduce intraocular pressure in patients with glaucoma and ocular hypertension. It is also used in cardiology to manage...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian